Life science leaders Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have officially formed a strategic alliance. This partnership aims to... Read more
Category: Uncategorized
J&J receives fda approval for innovative lung cancer therapy
The U.S. Food and Drug Administration (FDA) has officially granted approval for Rybrevant Faspro, a therapy targeting epidermal growth factor... Read more
Nxera seeks new buyer for schizophrenia program following boehringer snub
Nxera Pharma (formerly Sosei Group) is actively seeking buyers or strategic partners for its schizophrenia drug program after Boehringer Ingelheim... Read more
Eli lilly’s oral weight maintenance drug yields positive clinical results
Pharmaceutical giant Eli Lilly has released Phase III (ATTAIN-MAINTAIN) data for orforglipron, an oral GLP-1 receptor agonist. The drug is... Read more
Biomarin executes record-breaking $4.8 billion acquisition of amicus therapeutics
Biopharmaceutical giant BioMarin has announced an agreement to acquire Amicus Therapeutics for $4.8 billion. This transaction represents the largest in... Read more
Nine pharma giants reach drug price deals with trump administration
In a landmark move, nine multinational pharmaceutical companies have signed agreements with the White House to lower prices for various... Read more
Completion of construction for two major end-line hospital campuses
On the morning of December 19, the healthcare sector marked a significant milestone with the inauguration of the construction phase... Read more
Leveraging mrna technology and viral spike proteins for cancer therapy
Researchers at Binghamton University (USA) have announced a breakthrough approach in developing cancer treatment vaccines. By combining mRNA technology with... Read more
Implementation of artificial intelligence for cervical cancer screening at hung vuong hospital
At a medical symposium held on the morning of December 20, healthcare experts announced positive outcomes from integrating Artificial Intelligence... Read more









